Concepedia

Sean P. Hollinshead

SP

Statistics

Publications

27

Citations

987

H-Index

18

Active since

1985

Affiliations

Eli Lilly (United States)(Current)

Eli Lilly (United Kingdom)

University of York

University of Wisconsin–Milwaukee

Sean P. Hollinshead is an author at Eli Lilly (United States) specializing in chemistry, medicinal chemistry, and organic chemistry.

Publications per year

1985–2016

27

Publications

27

Structural requirements for agonist actions at the benzodiazepine receptor: studies with analogs of 6-(benzyloxy)-4-(methoxymethyl)-.beta.-carboline-3-carboxylic acid ethyl ester

Sean P. Hollinshead, Mark L. Trudell, Phil Skolnick et al. · Journal of Medicinal Chemistry · 1990 · 105 citations

, , +12

Diastereo- and enantio-selectivity in the Pictet–Spengler reaction

Patrick D. Bailey, Sean P. Hollinshead, Neil McLay et al. · Journal of the Chemical Society Perkin Transactions 1 · 1993 · 90 citations

, , +11

Identification and Pharmacological Profile of a New Class of Selective Nicotinic Acetylcholine Receptor Potentiators

Lisa M. Broad, Ruud Zwart, Kathy H. Pearson et al. · Journal of Pharmacology and Experimental Therapeutics · 2006 · 86 citations

, , +17

Tricyclic isoxazoles are novel inhibitors of the multidrug resistance protein (MRP1)

Bryan H. Norman, Joseph M. Gruber, Sean P. Hollinshead et al. · Bioorganic & Medicinal Chemistry Letters · 2002 · 66 citations · Full text

, , +9

Discovery of the First α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptor Antagonist Dependent upon Transmembrane AMPA Receptor Regulatory Protein (TARP) γ-8

Kevin M. Gardinier, Douglas L. Gernert, Warren J. Porter et al. · Journal of Medicinal Chemistry · 2016 · 60 citations · Full text

, , +17

1–5 of 27